CohBar upgraded by WBB Securities with a new price target
$CWBR
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
WBB Securities upgraded CohBar from Speculative Buy to Buy and set a new price target of $5.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/11/2021 | $5.00 | Speculative Buy → Buy | WBB Securities |